Bivalent rLukS-PV/rAT vaccine (Biota Pharmaceuticals)

N/A

Report date: 2022/11/27 16:44:51

Base Information

Drug NameBivalent rLukS-PV/rAT vaccine (Biota Pharmaceuticals)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Toxoid vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsStaphylococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSpero Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSpero Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A